SH

Siddique Hussain Koya

Active Director Director DIN 11029225
DIN 11029225 First appointment Mar 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Siddique Hussain Koya

Data last updated:

Siddique Hussain Koya is a Director at Ayurvaidyam Pharmaceuticals Private Limited (since 2025). The company operates in Paper.

DIN 11029225
Primary Designation Director
Industry Paper
First Appointment 30 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Mar 20252025Active

Directorship timeline

Open interactive timeline →
Ayurvaidyam Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Siddique Hussain Koya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siddique Hussain Koya

Siddique Hussain Koya currently holds 1 directorship: Ayurvaidyam Pharmaceuticals Private Limited (Director, since 30 Mar 2025).

Siddique Hussain Koya was first appointed on 30 Mar 2025 as Director at Ayurvaidyam Pharmaceuticals Private Limited.

The current boards of Siddique Hussain Koya's companies include Insaf Abdul Ismail (Ayurvaidyam Pharmaceuticals Private Limited), Muhammed Bilal (Ayurvaidyam Pharmaceuticals Private Limited), Noufal Hameed (Ayurvaidyam Pharmaceuticals Private Limited), Saifudeen Muhammad Mufassir Hussain (Ayurvaidyam Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available